The John Black Senior Research Fellowship aims to build on the strengths of the University's Central Nervous System (CNS) research programmes and world leading research into the discovery and translation of novel therapeutic approaches for neurodegenerative diseases, with a particular focus on Parkinson's disease. As a principal investigator, Dr Milosevic will provide strategic and academic leadership, pioneering studies and development of worldwide scientific collaborations.
"My colleagues and I are delighted to be welcoming Dr Milosevic to the University of Oxford and Nuffield Department of Medicine", says Dr Davis, CSO of the ARUK Oxford Drug Discovery Institute (ODDI), "Disturbances in the normal function of subcellular organelles has been highlighted as a possible cause of several neurodegenerative diseases and Ira's expertise in the field will provide a major boost to expansion of our understanding of the functional genetics of Parkinson's disease, in particular".
Dr Milosevic, who joins the University from the European Neuroscience Institute – Göttingen, said: "I am honoured to accept the John Black Senior Research Fellowship and excited to be joining the University of Oxford. I am extremely grateful to the John Black Charitable Foundation for providing financial support and for their efforts to promote translational research in Parkinson's disease. I look forward to helping advance their important mission and to collaborating with the exceptional faculty and students at the Nuffield Department of Medicine and Wellcome Centre for Human Genetics. "
About the John Black Charitable Foundation
John Black Charitable Foundation (JBCF) was created out of the Will of the Late John Black. The aim of JBCF is to promote quality research in the areas of Parkinson's disease and Prostate Cancer. Since its inception, JBCF has committed substantial funding for a large number of research projects at many of the UK's leading institutions.